|
Volumn 52, Issue 1, 2002, Pages 14-20
|
General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome: 1st Communication: Effects on general behavior and central nervous system
a a a a a |
Author keywords
CAS 153504 70 2; Cevimeline; Muscarinic agonist; Sj gren's syndrome; SNI 2011, general pharmacology
|
Indexed keywords
CEVIMELINE;
CHOLINERGIC RECEPTOR;
MUSCARINIC AGENT;
MUSCARINIC RECEPTOR BLOCKING AGENT;
SNI 2011;
THIOPENTAL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CAT;
CENTRAL NERVOUS SYSTEM;
CONTROLLED STUDY;
CONVULSION;
DRUG STRUCTURE;
ELECTROENCEPHALOGRAM;
GRIP STRENGTH;
HYPOTHERMIA;
MALE;
MOTOR COORDINATION;
MOUSE;
MYDRIASIS;
NONHUMAN;
RAT;
SALIVATION;
SJOEGREN SYNDROME;
SLEEP TIME;
TREMOR;
WRITHING TEST;
XEROSTOMIA;
|
EID: 0036149796
PISSN: 00044172
EISSN: None
Source Type: Journal
DOI: 10.1055/s-0031-1299850 Document Type: Article |
Times cited : (12)
|
References (15)
|